Pluri Inc. Other Significant Noncash Transaction, Value of Consideration Given
Pluri Inc. (PLUR) reported Other Significant Noncash Transaction, Value of Consideration Given of $790.00 thousand for the 12-month period ending 2015-06-30, per its 10-K filed 2017-09-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationGiven1 · last filed 2017-09-07
- Pluri Inc. other significant noncash transaction, value of consideration given for the quarter ending 2014-09-30 was $2.00K.
- Pluri Inc. other significant noncash transaction, value of consideration given for fiscal 2015 was $790.00K.
- Pluri Inc. other significant noncash transaction, value of consideration given for fiscal 2012 was $13.00K.
| Period end | Other Significant Noncash Transaction, Value of Consideration Given 3 month | Other Significant Noncash Transaction, Value of Consideration Given 12 month |
|---|---|---|
| 2015-06-30 | $790.00K 10-K · filed 2017-09-07 | |
| 2014-09-30 | $2.00K 10-Q · filed 2015-11-05 | |
| 2012-06-30 | $13.00K 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |